Baseline Characteristics of Patients Diagnosed with Systemic Lupus Erythematosus Initiating Treatment with Intravenous Belimumab

被引：0
|
作者：
Bell, Christopher F. [1 ]
Priest, Julie [1 ,2 ,3 ]
Amelio, Justyna [4 ]
Song, Xue [5 ]
Kan, Hong [6 ]
Stott-Miller, Marni [7 ]
Limone, Brendan [5 ]
Noxon, Virginia [5 ]
Costenbader, Karen H. [8 ,9 ]
机构：
[1] GSK US Value Evidence & Outcomes, Res Triangle Pk, NC USA
[2] US Hlth Outcomes, Durham, NC USA
[3] ViiV Healthcare, Durham, NC USA
[4] GSK Real World Evidence & Epidemiol, Stevenage, Herts, England
[5] Truven Hlth Analyt, Ann Arbor, MI USA
[6] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[7] GSK Real World Evidence & Epidemiol, Uxbridge, Middx, England
[8] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA
[9] Harvard Med Sch, Boston, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2593
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Pharmacokinetics and Exposure-response of Intravenous Belimumab in Children with Systemic Lupus Erythematosus
    Dimelow, Richard
    Ji, Beulah
    Struemper, Herbert
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [42] Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?
    Rua-Figueroa, Inigo
    Altabas-Gonzalez, Irene
    Mourino, Coral
    Roberts, Karen
    Hernandez-Martin, Andrea
    Casafont-Sole, Ivette
    Font-Urgelles, Judit
    Roman-Ivorra, Jose A.
    Navarro, Marta de la Rubia
    Galindo-Izquierdo, Maria
    Salman-Monte, Tarek C.
    Narvaez, Javier
    Vidal-Montal, Paola
    Garcia-Villanueva, Maria Jesus
    Garrote-Corral, Sandra
    Blazquez-Canamero, Maria Angeles
    Fernandez-Cid, Carlos Marras
    Piqueras-Garcia, Maria
    Martinez-Barrio, Julia
    Sanchez-Lucas, Marina
    Cortes-Hernandez, Josefina
    Penzo, Eleonora
    Calvo-Alen, Jaime
    de Dios, Juan Ramon
    Alvarez-Rodriguez, Belen
    Vasques-Rocha, Margarida
    Tomero, Eva
    Menor-Almagro, Raul
    Gandia, Myriam
    Gomez-Puerta, Jose A.
    Frade-Sosa, Beatriz
    Ramos-Giraldez, Consuelo
    Trapero-Perez, Carmen
    Diez, Elvira
    Moriano, Clara
    Munoz-Jimenez, Alejandro
    Pego-Reigosa, Jose Maria
    RHEUMATOLOGY, 2024,
  • [43] Impact of Baseline Concomitant Medication Use on Belimumab Efficacy and Safety in Patients with Systemic Lupus Erythematosus (SLE)
    Schwarting, Andreas
    Dooley, Mary Anne
    Roth, David
    Edwards, Lisa
    Thompson, April
    Wilson, Barbara
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [44] Intravenous immunoglobulin treatment of 100 systemic lupus erythematosus patients
    Sherer, Y
    Levy, Y
    Kuechler, S
    Scali, J
    Rovensky, J
    Goddard, G
    Shoenfeld, Y
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 235 - 236
  • [45] Belimumab for systemic lupus erythematosus - Focus on lupus nephritis
    Pluess, Marlene
    Piantoni, Silvia
    Tampe, Bjoern
    Kim, Alfred H. J.
    Korsten, Peter
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [46] SPANISH NATIONAL REGISTRY OF BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Laino, M.
    Enguita, M.
    Castaneda, S.
    Loricera, J.
    Moriano, C.
    Lasa, C.
    Calvo-Rio, V.
    Narvaez, J.
    Navarro Palomo, P.
    Casafont-Sole, I.
    Font, J.
    Gallego, A.
    Carrion Barbera, I.
    Quiroga Colino, P.
    Garcia-Aparicio, A.
    Belzunegui Otano, J. M.
    Lopez, M.
    Jimenez de Aberasturi, J. R. De Dios
    Hernandez, S.
    Heredia, S.
    Farina, A.
    Navarro Blasco, F. J.
    Ortega Castro, R.
    Del Olmo Perez, L.
    Labrador-Sanchez, E.
    Pinillos, V.
    Ortega de la O, M. C.
    Castro, P.
    Blanco, J. M.
    Paulino Huertas, M.
    Matias de la Mano, M. A.
    Peralta-Gines, C.
    Garcia-Cirera, S.
    Camins, J.
    Urruticoechea-Arana, A.
    Medina Malone, M.
    Cossio Jimenez, P. J.
    Perez-Pampin, E.
    Varas, B.
    Vazquez, C.
    Vegas-Revenga, N.
    Rusinovich, O.
    Giner, E.
    Lamua-Riazuelo, J. R.
    Aldasoro, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 899 - 901
  • [47] Spanish National Registry of Belimumab in Patients with Systemic Lupus Erythematosus
    Aldasoro, Vicente
    Laino, Maria
    Enguita, Monica
    Castaneda, Santos
    Loricera, Javier
    Lasa-Teja, Carmen
    Moriano, Clara
    Rio, Vanesa Calvo
    Casafont-Sole, Ivette
    Font Urgelles, Judit
    Quiroga-Colina, Patricia
    Hernandez, Samuel
    Heredia, Sergi
    Garcia-Aparicio, A.
    Belzunegui Otano, Joaquin Maria
    Farina, Aaron
    Navarro Blasco, Francisco Javier
    Fanlo Mateo, Patricia
    Gallego, Adela
    Blanco Madrigal, Juan M.
    Angeles Matias, Maria
    Peralta, Cilia
    Camins-Fabregas, Jordi
    Paulino, Marcos
    Urruticoechea, Ana
    Cossio Jimenez, Piter Jose
    Medina Malone, Miguel
    Perez Pampin, Eva
    Ortega-Castro, Rafaela
    Varas de Dios, Blanca
    Lamua Riazuelo, Jose Ramon
    Jose Giner, Emilio
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 692 - 695
  • [48] Efficacy and safety data of belimumab in patients with systemic lupus erythematosus
    Shakoory, Bita
    Clatham, Winn
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2011, 3 (03) : 159 - 164
  • [49] COMBINATION THERAPY WITH RITUXIMAB AND BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Mesnyankina, A.
    Aseeva, E.
    Nikishina, N.
    Torgashina, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1168 - 1168
  • [50] IMPROVEMENT OF BELIMUMAB ON QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Yi, G.
    Zheng, S.
    Guo, X.
    Liu, M.
    Li, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1351 - 1351
12345